ESLA
ESLA
NASDAQ · Biotechnology

Estrella Immunopharma Inc

$0.73
+0.01 (+0.90%)
As of Aug 15, 2:22 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,962.6% upside
Low Target $11.92
Average Target $15.08
High Target $19.61
Current Price $0.73
Current
$0.73
Target
$15.08
$11.92 $15.08 avg $19.61
Scenario Analysis
Bear Case
$11.92
1,530.4%
Low target
Base Case
$15.08
+1,962.6%
Avg target
Bull Case
$19.61
+2,582.3%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$3.15
-76.8% from high
52-Week Low
$0.68
+7.8% from low
Target vs 52W High
$15.08
+378.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%